Guardant Health, Inc.
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for…
Medical - Diagnostics & Research
US, Redwood City [HQ]
Cash Flow Statements
8 Sheets · Starting from 2023In Million USD. Margins, Growth Rates In %
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||
| Operating Cash Flow (OCF) | -36.00 | -72.00 | -72.00 | -47.00 | -103.00 | -209.00 | -309.00 | -324.00 | |
| Operating Cash (Net) | -36.00 | -72.00 | -72.00 | -47.00 | -103.00 | -209.00 | -309.00 | -324.00 | |
| Accounts Receivable | -2.00 | -9.00 | -22.00 | -7.00 | -5.00 | -44.00 | - - | 8.00 | |
| Accounts Payable | 2.00 | 1.00 | 5.00 | 4.00 | -7.00 | 8.00 | 60.00 | 88.00 | |
|
Working Capital
|
- - | - - | - - | - - | - - | - - | - - | - - | |
| Change | 2.00 | -4.00 | -1.00 | -6.00 | -47.00 | -40.00 | 61.00 | 53.00 | |
| Other WC | 3.00 | 7.00 | 18.00 | 3.00 | -26.00 | 3.00 | 21.00 | -32.00 | |
| Investing Activities | |||||||||
| Used Cash (Net) | 26.00 | -170.00 | -153.00 | -317.00 | -617.00 | -63.00 | 149.00 | 840.00 | |
| Capital Expenditure | -1.00 | -8.00 | -20.00 | -21.00 | -54.00 | -75.00 | -77.00 | -20.00 | |
| Purchases of Investments | -341.00 | -236.00 | -287.00 | -614.00 | -1,125.00 | -940.00 | -327.00 | -635.00 | |
| Sale/Maturity of Investment | 369.00 | 75.00 | 154.00 | 325.00 | 562.00 | 952.00 | 555.00 | 1,494.00 | |
| Property, Plant, Equipment (P&PE) | -1.00 | -8.00 | -20.00 | -21.00 | -54.00 | -75.00 | -77.00 | -20.00 | |
| Acquisitions (Net) | - - | 2.00 | - - | -7.00 | 17.00 | -11.00 | -227.00 | - - | |
| Other Investing Activities | - - | -2.00 | - - | - - | -17.00 | 11.00 | 227.00 | 1.00 | |
| Financing Activities | |||||||||
| Used Cash (Net) | -39.00 | -281.00 | -293.00 | -367.00 | -1,410.00 | -66.00 | -189.00 | -477.00 | |
| Debt Repayment | - - | -26.00 | - - | - - | - - | - - | - - | - - | |
| Dividends Paid | - - | - - | -3.00 | - - | - - | - - | - - | - - | |
|
Common Stock
|
- - | 13 | 254 | - - | 348 | 101 | 19 | 493 | |
| Issued | - - | - - | 254.00 | 367.00 | 355.00 | 17.00 | 11.00 | 482.00 | |
| Repurchased | - - | -12.00 | - - | - - | 7.00 | -83.00 | -7.00 | -11.00 | |
| Other Financing Activities | 40.00 | 319.00 | 42.00 | 367.00 | 1,054.00 | -83.00 | -200.00 | -5.00 | |
| Cash Balances | |||||||||
| Begin of Period | 4.00 | 33.00 | 72.00 | 140.00 | 143.00 | 832.00 | 492.00 | 141.00 | |
| End of Period | 33.00 | 72.00 | 140.00 | 143.00 | 832.00 | 492.00 | -350.00 | 1,133.00 | |
| Change | 29.00 | 39.00 | 67.00 | 2.00 | 689.00 | -340.00 | -842.00 | 991.00 | |
| Non-Cash Balances | |||||||||
| Depreciation and Amortization | 3.00 | 5.00 | 7.00 | 13.00 | 16.00 | 22.00 | 35.00 | 42.00 | |
| Stock Based Compensation | 1.00 | 3.00 | 6.00 | 16.00 | 144.00 | 151.00 | 94.00 | 90.00 | |
| Other | 1.00 | - - | - - | -2.00 | 18.00 | 29.00 | 152.00 | 53.00 | |
| Highlighted metrics | |||||||||
| Free Cash Flow (FCF) | -38.00 | -81.00 | -92.00 | -68.00 | -157.00 | -284.00 | -386.00 | -345.00 | |
| Cash Conversion Cycle (CCC) | 44.00 | 120.00 | 131.00 | 76.00 | 128.00 | 134.00 | -211.00 | 73.00 | |
| Invested Capital | - - | - - | - - | - - | - - | - - | - - | - - | |
|
Other Operating Inflows/Outflows
|
|||||||||
| Forex Effect on Cash | - - | - - | - - | - - | - - | -1.00 | -1.00 | - - |